New study examines SM burden from both patient and provider perspectives
A first-of-its-kind study in Europe identified sources of disease burden as reported by patients with SM and their healthcare providers.
A first-of-its-kind study in Europe identified sources of disease burden as reported by patients with SM and their healthcare providers.
A clinical trial of 16 patients with indolent SM found that sarilumab does not significantly improve quality of life.
A patient who was diagnosed with mast cell leukemia, a rare form of SM, experienced symptom relief with methylprednisolone treatment.
A 9-year-old girl underwent a stem cell transplant after being diagnosed with SM following treatment for a germ cell tumor.
A case report describes a patient who experienced two failed transcatheter aortic valve replacements, likely related to her underlying SM.
Duplex sequencing can reveal KIT mutations in a subset of patients with SM who do not have detectable mutations by ddPCR, a study found.
Rare Disease Day 2025 aims to uplift the rare disease community and promote greater awareness.
A recent case report illustrated the need for thorough care to prevent adverse postoperative outcomes in patients with SM.
A case study illustrated the difficulty of diagnosing systemic mastocytosis (SM), particularly in children.
A new study is recruiting participants and will evaluate the safety of avapritinib in treating SM over a period of four years.